Mirae Asset Global ETFs Holdings’s CorMedix CRMD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$242K	Buy	35,680 +1,215	+4%	+$8.98K	﹤0.01%	2254
2025 Q4	$401K	Buy	34,465 +1,739	+5%	+$19.2K	﹤0.01%	1994
2025 Q3	$381K	Buy	+32,726	New	+$396K	﹤0.01%	2002
2025 Q2	–	Sell	-35,987	Closed	-$222K	–	3054
2025 Q1	$222K	Buy	35,987 +1,631	+5%	+$16.9K	﹤0.01%	2271
2024 Q4	$278K	Buy	34,356 +4,295	+14%	+$42.9K	﹤0.01%	2217
2024 Q3	$243K	Buy	30,061 +2,402	+9%	+$13K	﹤0.01%	2279
2024 Q2	$120K	Buy	+27,659	New	+$141K	﹤0.01%	2491

Other funds holding CRMD

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Mirae Asset Global ETFs Holdings's CRMD Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its CorMedix (CRMD) stake by 3.5% in Q1 2026, buying an estimated $8.98K and bringing the position to 35,680 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #2254.

Mirae Asset Global ETFs Holdings first reported a position in CRMD in Q2 2024 and has held it in 7 quarters since. The position peaked at $401K in Q4 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

Mirae Asset Global ETFs Holdings held 35,680 shares of CorMedix worth $242K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 1,215 CorMedix shares in Q1 2026, an estimated $8.98K.
CorMedix made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2254 holding.
Mirae Asset Global ETFs Holdings first reported a position in CorMedix in Q2 2024 and has held it in 7 quarters since.
Mirae Asset Global ETFs Holdings's CorMedix position peaked at $401K in Q4 2025.
187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.